EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multimeric Conjugates Using Engineered Peptide Scaffolds for Efficient siRNA Delivery

Quentin Vicentini iD, Dennis Hekman, Deepak Bhatt, Rouven Stulz, Mahya Dezfouli, Peter Gennemark iD, Nicola Guzzi, Naoko Toki, Bojana Lazovic, Carolina Tängemo, Shalini Andersson, Samir El Andaloussi und 1 weitere

Bioconjugate Chemistry · 2025

DOI: 10.1021/acs.bioconjchem.5c00156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2025. Verfasst von Quentin Vicentini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cell, Genes and RNA Therapy, Discovery Sciences, Biopharmaceuticals R&D-AstraZeneca Gothenburg, 43183 Mölndal, Sweden. Hauptthemen laut MEDLINE: RNA, Small Interfering, Peptides, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vetenskapsr?det, Novo Nordisk, Swedish Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligonucleotide therapeutics (ONT) traditionally involve a single targeting moiety per oligonucleotide when conjugated for organ delivery. Multimerization represents a novel approach by connecting multiple ONTs to a single scaffold, thereby influencing the drug's activity and biophysical properties in vivo. Recently, others have demonstrated the efficacy of this strategy, showing enhanced tissue retention and extended silencing with the capability to target multiple genes simultaneously. The investigation of diverse multimeric designs is thus an exciting opportunity to explore the delivery of the ONT. In this study, we engineered a versatile peptide branching unit able to link up to four small interfering RNAs together. We conjugated a GalNAc targeting moiety to these scaffolds for liver hepatocyte delivery and assessed their silencing activity. Our approach was further expanded to explore different peptide architectures (linear versus cyclized) and additional functionalities, including endosomal escape domains and dual target silencing. We then evaluated the constructs via subcutaneous and intravenous (i.v.) administration in mice. Notably, the intravenous administration of multimeric siRNA GalNAc demonstrated potent silencing in the liver and significantly affected liver-to-kidney biodistribution. Our findings suggest that peptides as branching units offer a promising pathway for ONT multimerization, advancing the challenges of drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingPeptidesDrug Delivery SystemsAnimalsMiceHumansLiverTissue DistributionGene SilencingAcetylgalactosamineHepatocytes

Substanzen

RNA, Small InterferingPeptidesAcetylgalactosamine

Autor:innen und Institutionen

  • Cell, Genes and RNA Therapy, Discovery Sciences, Biopharmaceuticals R&D-AstraZeneca Gothenburg, 43183 Mölndal, Sweden.
  • Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14152 Stockholm, Sweden.
  • Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden.
  • Assays, Profiling and Cell Sciences, Discovery Sciences, Biopharmaceuticals R&D-AstraZeneca, Mölndal, 431 83 Gothenburg, Sweden.
  • Department of Biomedical Engineering, Linköping University, 581 85 Linköping, Sweden.
  • Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D-AstraZeneca, Mölndal, 431 83 Gothenburg, Sweden.

ORCID-Profile: Quentin Vicentini, Peter Gennemark, Anders Dahlén

Förderung

  • Vetenskapsr?det
  • Novo Nordisk
  • Swedish Cancer Foundation
  • H2020 Marie Sklodowska-Curie Actions
  • Stiftelsen f?r?Strategisk Forskning
  • Horizon 2020 Framework Programme

Zitieren

APA

Vicentini, Q., Hekman, D., Bhatt, D., Stulz, R., Dezfouli, M., Gennemark, P., Guzzi, N., Toki, N., Lazovic, B., Tängemo, C., Andersson, S., El Andaloussi, S., & Dahlén, A. (2025). Multimeric Conjugates Using Engineered Peptide Scaffolds for Efficient siRNA Delivery. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00156

Vancouver

Vicentini Q, Hekman D, Bhatt D, Stulz R, Dezfouli M, Gennemark P, et al. Multimeric Conjugates Using Engineered Peptide Scaffolds for Efficient siRNA Delivery. Bioconjugate Chemistry. 2025. doi:10.1021/acs.bioconjchem.5c00156

BibTeX
@article{Vicentini2025,
  author = {Vicentini, Quentin and Hekman, Dennis and Bhatt, Deepak and Stulz, Rouven and Dezfouli, Mahya and Gennemark, Peter and Guzzi, Nicola and Toki, Naoko and Lazovic, Bojana and Tängemo, Carolina and Andersson, Shalini and El Andaloussi, Samir and Dahlén, Anders},
  title = {Multimeric Conjugates Using Engineered Peptide Scaffolds for Efficient siRNA Delivery},
  journal = {Bioconjugate Chemistry},
  year = {2025},
  doi = {10.1021/acs.bioconjchem.5c00156}
}
Kostenlos starten →